The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
Dana M. Brantley‐Sieders(Vanderbilt University Medical Center), Jin Chen(Breast Cancer Research Foundation)
Cited by 276
Related Papers
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer
|Journal of Clinical Investigation|2020|348
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
|Oncogene|2017|95
mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis
|PLoS Genetics|2015|47
VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity
|PLoS ONE|2012|34
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
|F1000Research|2020|16